Encompass Health (EHC) Forms $57.22 Double Top; Randgold Resources Limited (LON:RRS) Covered By 15 Bullish Analysts Last Week

April 17, 2018 - By Stephen Andrade

Encompass Health Corporation (EHC) formed double top with $61.80 target or 8.00% above today’s $57.22 share price. Encompass Health Corporation (EHC) has $5.62B valuation. The stock increased 0.65% or $0.37 during the last trading session, reaching $57.22. About 851,018 shares traded or 44.32% up from the average. Encompass Health Corporation (NYSE:EHC) has risen 32.77% since April 17, 2017 and is uptrending. It has outperformed by 21.22% the S&P500.

Among 25 analysts covering Randgold Resources Ltd (LON:RRS), 15 have Buy rating, 4 Sell and 6 Hold. Therefore 60% are positive. Randgold Resources Ltd had 229 analyst reports since July 22, 2015 according to SRatingsIntel. The rating was maintained by Panmure Gordon with “Hold” on Thursday, November 3. The stock of Randgold Resources Limited (LON:RRS) has “Neutral” rating given on Tuesday, May 17 by Macquarie Research. RBC Capital Markets upgraded the stock to “Sector Performer” rating in Monday, December 4 report. The firm has “Reduce” rating by Nomura given on Wednesday, September 2. Deutsche Bank maintained Randgold Resources Limited (LON:RRS) rating on Friday, November 6. Deutsche Bank has “Buy” rating and GBX 5050 target. The stock has “Hold” rating by Deutsche Bank on Monday, June 6. The stock has “Overweight” rating by Barclays Capital on Tuesday, November 10. The stock of Randgold Resources Limited (LON:RRS) has “Buy” rating given on Tuesday, December 5 by Citigroup. Barclays Capital maintained the shares of RRS in report on Thursday, May 5 with “Overweight” rating. Jefferies maintained Randgold Resources Limited (LON:RRS) on Tuesday, April 18 with “Buy” rating. See Randgold Resources Limited (LON:RRS) latest ratings:

04/04/2018 Broker: JP Morgan Rating: Neutral Old Target: GBX 7000.00 New Target: GBX 7300.00 Maintain
04/04/2018 Broker: RBC Capital Markets Rating: Underperform Old Target: GBX 6600.00 Downgrade
28/03/2018 Broker: Morgan Stanley Rating: Overweight Maintain
13/03/2018 Broker: Canaccord Genuity Rating: Buy Old Target: GBX 7500.00 New Target: GBX 7000.00 Reiteration
15/02/2018 Broker: Morgan Stanley Rating: Overweight Old Target: GBX 7230.00 New Target: GBX 7140.00 Maintain
08/02/2018 Broker: HSBC Rating: Buy Old Target: GBX 7800.00 New Target: GBX 7700.00 Upgrade
06/02/2018 Broker: Numis Securities Rating: Add Old Target: GBX 9000.00 New Target: GBX 8000.00 Lowers
01/02/2018 Broker: Credit Suisse Rating: Neutral Old Target: GBX 7160.00 New Target: GBX 7160.00 Maintain
30/01/2018 Broker: Credit Suisse Rating: Neutral Old Target: GBX 7160.00 New Target: GBX 7160.00 Maintain
24/01/2018 Broker: JP Morgan Rating: Neutral Old Target: GBX 7000.00 New Target: GBX 7000.00 Maintain

Randgold Resources Limited explores for and develops gold deposits in Sub-Saharan Africa. The company has market cap of 5.32 billion GBP. It holds interests in the Morila gold mine, the Loulo gold mine, and the Gounkoto gold mine, which are located in Mali, West Africa; Tongon mine situated within the Nielle exploitation permit in the north of Côte d’Ivoire; and Kibali mine located in the Democratic Republic of Congo. It has a 19.32 P/E ratio. The firm was founded in 1995 and is based in St.

The stock decreased 0.04% or GBX 2 during the last trading session, reaching GBX 5642. About 66,941 shares traded. Randgold Resources Limited (LON:RRS) has 0.00% since April 17, 2017 and is . It has underperformed by 11.55% the S&P500.

Analysts await Encompass Health Corporation (NYSE:EHC) to report earnings on April, 26 after the close. They expect $0.81 EPS, up 15.71% or $0.11 from last year’s $0.7 per share. EHC’s profit will be $79.50M for 17.66 P/E if the $0.81 EPS becomes a reality. After $0.70 actual EPS reported by Encompass Health Corporation for the previous quarter, Wall Street now forecasts 15.71% EPS growth.

Encompass Health Corporation (NYSE:EHC) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Stephen Andrade

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: